Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. has announced the quotation of 555,009,026 fully paid ordinary shares on the Australian Securities Exchange (ASX), effective from December 9, 2024. This development is part of previously announced transactions and is set to enhance the trading activity of Chimeric’s shares, potentially attracting more investors. The move reflects the company’s strategic efforts to expand its market presence.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.